Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center’s real-world study by Yongbao Wei, Yongbao Wei, Ruochen Zhang, Ruochen Zhang, Chenbo Yu, Chenbo Yu, Zhiwei Hong, Zhiwei Hong, Le Lin, Le Lin, Tao Li, Tao Li, Jianhui Chen

Get full text